L. Robert Nussbaum's Insider Trades & SAST Disclosures
L. Robert Nussbaum's most recent trade in Invitae Corp was a trade of 17,404 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Dec. 20, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern L. Robert Nussbaum.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Invitae Corp | L. Robert Nussbaum | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 20 Dec 2023 | 17,404 | 551,941 (0%) | 0% | 0.6 | 11,278 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 13 Jun 2023 | 7,086 | 569,345 (0%) | 0% | 1.4 | 9,757 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 26,476 | 576,431 (0%) | 0% | 1.2 | 31,753 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 155,000 | 602,907 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 13 Mar 2023 | 2,625 | 447,907 (0%) | 0% | 1.4 | 3,701 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 54,000 | 450,532 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 16 Aug 2022 | 7,048 | 396,532 (0%) | 0% | 4.6 | 32,071 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 6,098 | 403,580 (0%) | 0% | 3.8 | 23,234 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 168,511 | 409,678 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 19,588 | 241,167 (0%) | 0% | 6.7 | 130,993 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 14,705 | 260,755 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.89 per share. | 11 Nov 2021 | 29,675 | 246,050 (0%) | 0% | 21.9 | 649,568 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 16,406 | 53,594 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.23 per share. | 11 Nov 2021 | 16,406 | 275,725 (0%) | 0% | 10.2 | 167,833 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 13,269 | 40,080 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 11 Nov 2021 | 13,269 | 259,319 (0%) | 0% | 9.9 | 131,363 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 16 Aug 2021 | 21,231 | 246,050 (0%) | 0% | 25.4 | 539,633 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 9,910 | 266,879 (0%) | 0% | 31.6 | 313,405 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 44,700 | 276,789 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Employee Stock Option (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 11,894 | 238,354 (0%) | 0% | 42.9 | 510,260 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 6,265 | 232,089 (0%) | 0% | 42.9 | 268,772 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 06 Jan 2021 | 10,101 | 225,312 (0%) | 0% | 9.9 | 100,000 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 10,101 | 53,349 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2020 | 6,550 | 63,450 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 09 Oct 2020 | 6,550 | 215,211 (0%) | 0% | 9.9 | 64,845 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 10 Sep 2020 | 11,497 | 210,391 (0%) | 0% | 33.9 | 389,345 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 10 Sep 2020 | 9,391 | 221,888 (0%) | 0% | 33.0 | 309,591 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.69 per share. | 10 Sep 2020 | 1,730 | 208,661 (0%) | 0% | 34.7 | 60,012 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 557 | 231,279 (0%) | 0% | 33.9 | 18,864 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,106 | 231,836 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 19,049 | 230,730 (0%) | 0% | 32.1 | 611,399 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.31 per share. | 09 Jul 2020 | 22,347 | 251,229 (0%) | 0% | 34.3 | 766,634 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 09 Jul 2020 | 5,986 | 273,576 (0%) | 0% | 33.4 | 199,829 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.93 per share. | 09 Jul 2020 | 1,450 | 249,779 (0%) | 0% | 34.9 | 50,649 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 59,150 | 279,562 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 19,600 | 19,600 | - | - | Employee Stock Option (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 03 Jun 2020 | 20,000 | 220,412 (0%) | 0% | 9.9 | 198,000 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2020 | 20,000 | 70,000 | - | - | Employee Stock Option (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 20 May 2020 | 16,859 | 203,446 (0%) | 0% | 17.2 | 290,292 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 6,864 | 220,305 (0%) | 0% | 16.7 | 114,634 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.62 per share. | 20 May 2020 | 3,034 | 200,412 (0%) | 0% | 17.6 | 53,471 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges